201 related articles for article (PubMed ID: 16529563)
1. What do we know about duloxetine's mode of action? Evidence from animals to humans.
Schuessler B
BJOG; 2006 May; 113 Suppl 1():5-9. PubMed ID: 16529563
[TBL] [Abstract][Full Text] [Related]
2. Serotonin and norepinephrine involvement in efferent pathways to the urethral rhabdosphincter: implications for treating stress urinary incontinence.
Thor KB
Urology; 2003 Oct; 62(4 Suppl 1):3-9. PubMed ID: 14550831
[TBL] [Abstract][Full Text] [Related]
3. Duloxetine: mechanism of action at the lower urinary tract and Onuf's nucleus.
Jost W; Marsalek P
Clin Auton Res; 2004 Aug; 14(4):220-7. PubMed ID: 15316838
[TBL] [Abstract][Full Text] [Related]
4. Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence.
Zinner NR
Expert Opin Investig Drugs; 2003 Sep; 12(9):1559-66. PubMed ID: 12943499
[TBL] [Abstract][Full Text] [Related]
5. Effect of duloxetine, a norepinephrine and serotonin reuptake inhibitor, on sneeze-induced urethral continence reflex in rats.
Miyazato M; Kaiho Y; Kamo I; Chancellor MB; Sugaya K; de Groat WC; Yoshimura N
Am J Physiol Renal Physiol; 2008 Jul; 295(1):F264-71. PubMed ID: 18480175
[TBL] [Abstract][Full Text] [Related]
6. Duloxetine: a new approach for treating stress urinary incontinence.
Moore K
Int J Gynaecol Obstet; 2004 Jul; 86 Suppl 1():S53-62. PubMed ID: 15302567
[TBL] [Abstract][Full Text] [Related]
7. Targeting serotonin and norepinephrine receptors in stress urinary incontinence.
Thor KB
Int J Gynaecol Obstet; 2004 Jul; 86 Suppl 1():S38-52. PubMed ID: 15302566
[TBL] [Abstract][Full Text] [Related]
8. Facilitatory neuromodulative effect of duloxetine on pudendal motor neurons controlling the urethral pressure: a functional urodynamic study in healthy women.
Boy S; Reitz A; Wirth B; Knapp PA; Braun PM; Haferkamp A; Schurch B
Eur Urol; 2006 Jul; 50(1):119-25. PubMed ID: 16455184
[TBL] [Abstract][Full Text] [Related]
9. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence.
Dmochowski RR; Miklos JR; Norton PA; Zinner NR; Yalcin I; Bump RC;
J Urol; 2003 Oct; 170(4 Pt 1):1259-63. PubMed ID: 14501737
[TBL] [Abstract][Full Text] [Related]
10. Neural control of the urethra and development of pharmacotherapy for stress urinary incontinence.
Fraser MO; Chancellor MB
BJU Int; 2003 May; 91(8):743-8. PubMed ID: 12709086
[TBL] [Abstract][Full Text] [Related]
11. The facilitatory effect of duloxetine combined with pelvic floor muscle training on the excitability of urethral sphincter motor neurons.
Mehnert U; Boy S; Widmer-Simitovic S; Reitz A; Schurch B
Int Urogynecol J Pelvic Floor Dysfunct; 2009 Jun; 20(6):659-66. PubMed ID: 19271093
[TBL] [Abstract][Full Text] [Related]
12. Duloxetine: in stress urinary incontinence.
McCormack PL; Keating GM
Drugs; 2004; 64(22):2567-73; discussion 2574-5. PubMed ID: 15516154
[TBL] [Abstract][Full Text] [Related]
13. Update on duloxetine for the management of stress urinary incontinence.
Basu M; Duckett JR
Clin Interv Aging; 2009; 4():25-30. PubMed ID: 19503763
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats.
Katofiasc MA; Nissen J; Audia JE; Thor KB
Life Sci; 2002 Aug; 71(11):1227-36. PubMed ID: 12106588
[TBL] [Abstract][Full Text] [Related]
15. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults.
Mariappan P; Ballantyne Z; N'Dow JM; Alhasso AA
Cochrane Database Syst Rev; 2005 Jul; (3):CD004742. PubMed ID: 16034945
[TBL] [Abstract][Full Text] [Related]
16. Central nervous system control of the lower urinary tract: new pharmacological approaches to stress urinary incontinence in women.
Thor KB; Donatucci C
J Urol; 2004 Jul; 172(1):27-33. PubMed ID: 15201731
[TBL] [Abstract][Full Text] [Related]
17. Coadministration of low-dose serotonin/noradrenaline reuptake inhibitor (SNRI) duloxetine with α 2-adrenoceptor blockers to treat both female and male mild-to-moderate stress urinary incontinence (SUI).
Alberti C
G Chir; 2013; 34(7-8):189-94. PubMed ID: 24091172
[TBL] [Abstract][Full Text] [Related]
18. The effect of duloxetine on urethral sphincter morphology.
Duckett J; Patil A; Aggarwal I
Ultrasound Obstet Gynecol; 2008 Feb; 31(2):206-9. PubMed ID: 18254135
[TBL] [Abstract][Full Text] [Related]
19. The treatment of urinary incontinence with Duloxetine.
Basu M; Duckett J
J Obstet Gynaecol; 2008 Feb; 28(2):166-9. PubMed ID: 18393011
[TBL] [Abstract][Full Text] [Related]
20. [Duloxetine. A new preparation for patients with urinary incontinence].
Walter S
Ugeskr Laeger; 2005 Nov; 167(48):4553-5. PubMed ID: 16324435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
